Bassem Zarif

Cairo, C, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Blood Pressure Variability (BPV): What Clinicians Need to Know a 2025 Expert Consensus Report Endorsed by the Egyptian Society of Cardiology.

Blood Pressure Variability (BPV): What Clinicians Need to Know a 2025 Expert Consensus Report Endorsed by the Egyptian Society of Cardiology.

Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension

Published: June 04, 2025

Dapagliflozin enhances systolic and diastolic function in concordance with clinical response in patients with left ventricular dysfunction.

Dapagliflozin enhances systolic and diastolic function in concordance with clinical response in patients with left ventricular dysfunction.

Journal: European review for medical and pharmacological sciences

Published: May 30, 2025

Effect of Pharmacogenetics on Renal Outcomes of Heart Failure Patients with Reduced Ejection Fraction (HFrEF) in Response to Dapagliflozin.

Effect of Pharmacogenetics on Renal Outcomes of Heart Failure Patients with Reduced Ejection Fraction (HFrEF) in Response to Dapagliflozin.

Journal: Pharmaceutics

Published: April 23, 2025

Genetic polymorphisms in SLC5A2 are associated with clinical outcomes and dapagliflozin response in heart failure patients.

Genetic polymorphisms in SLC5A2 are associated with clinical outcomes and dapagliflozin response in heart failure patients.

Journal: Frontiers in pharmacology

Published: December 05, 2024

Immediate and short-term outcomes of in-hospital canagliflozin initiation in acute heart failure: Results from the CANA-AHF randomized clinical trial.

Immediate and short-term outcomes of in-hospital canagliflozin initiation in acute heart failure: Results from the CANA-AHF randomized clinical trial.

Journal: Heart & lung : the journal of critical care

Published: September 24, 2024

ACE Inhibitors and Angiotensin Receptor Blockers for the Primary and Secondary Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus in Collaboration with the CVREP Foundation.

ACE Inhibitors and Angiotensin Receptor Blockers for the Primary and Secondary Prevention of Cardiovascular Outcomes: Recommendations from the 2024 Egyptian Cardiology Expert Consensus in Collaboration with the CVREP Foundation.

Journal: Cardiology and therapy

Published: June 10, 2024

Impact of health awareness on myocardial infarction.

Impact of health awareness on myocardial infarction.

Journal: The Journal of the Egyptian Public Health Association

Published: April 16, 2024

Intravascular ultrasound-guided percutaneous coronary intervention for patients with unprotected left main coronary artery lesions.

Intravascular ultrasound-guided percutaneous coronary intervention for patients with unprotected left main coronary artery lesions.

Journal: Coronary artery disease

Published: March 07, 2024

Impact of dapagliflozin on cardiac function following anterior myocardial infarction in non-diabetic patients - DACAMI (a randomized controlled clinical trial).

Impact of dapagliflozin on cardiac function following anterior myocardial infarction in non-diabetic patients - DACAMI (a randomized controlled clinical trial).

Journal: International journal of cardiology

Published: November 14, 2022

The five keys for a successful implementation of a cardiac telerehabilitation: a step-by-step effective digitalization of rehabilitation health services in Egypt.

The five keys for a successful implementation of a cardiac telerehabilitation: a step-by-step effective digitalization of rehabilitation health services in Egypt.

Journal: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology

Published: September 26, 2022

Testing P2Y12 platelet inhibitors generics beyond bioequivalence: a parallel single-blinded randomized trial.

Testing P2Y12 platelet inhibitors generics beyond bioequivalence: a parallel single-blinded randomized trial.

Journal: Thrombosis journal

Published: May 25, 2022

Boosting protection for patients with non-acute cardiovascular disease: a focus on antithrombotic regimen (a consensus expert opinion from the Egyptian Society of Cardiology working group of thrombosis and prevention).

Boosting protection for patients with non-acute cardiovascular disease: a focus on antithrombotic regimen (a consensus expert opinion from the Egyptian Society of Cardiology working group of thrombosis and prevention).

Journal: The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology

Published: November 08, 2021

Showing 1-12 of 12

Last Updated: 09/26/2026